Does Augmentin Cause Yeast Infections?
Yes, Augmentin (amoxicillin-clavulanate) does cause yeast infections, and this is a well-documented adverse effect of broad-spectrum antibiotic therapy. The FDA drug label explicitly states that "amoxicillin/clavulanate may reduce the efficacy of oral contraceptives" and notes that broad-spectrum antibiotics can disrupt normal flora 1. More importantly, the most recent high-quality comparative study from 2026 found that amoxicillin-clavulanate was associated with a significantly higher risk of yeast infections compared to amoxicillin alone (1.1% vs 0.8%; risk ratio 1.40,95% CI 1.29-1.53) 2.
Mechanism and Clinical Evidence
The risk is directly related to the disruption of normal bacterial flora, particularly in the gastrointestinal and genitourinary tracts. A prospective study demonstrated that amoxicillin-clavulanate caused a higher and more persistent increase in gastrointestinal colonization by yeasts compared to other antibiotics including ciprofloxacin, sulfamethoxazole-trimethoprim, or ampicillin alone 3. This disruption of the normal microbiome creates an environment where Candida species can overgrow.
Specific Risk Data
The evidence shows varying rates of yeast infections depending on the site and population:
- Vulvovaginal candidiasis: In a urinary tract infection treatment study, 14.2% of patients developed symptomatic candida vaginitis within one week after completing amoxicillin-clavulanate therapy 4
- General antibiotic use: A case-control study found that antibiotic use in the preceding month increased the odds of vulvovaginal candidiasis by 1.75 times (95% CI 1.33-2.32), with risk directly related to duration of antibiotic use 5
- Comparative risk: The 2026 study showed amoxicillin-clavulanate carries a 40% higher risk of yeast infections compared to amoxicillin alone 2
Clinical Implications
The addition of clavulanate to amoxicillin broadens the antimicrobial spectrum, which increases disruption of protective normal flora beyond what amoxicillin alone would cause. This is why the comparative data consistently shows higher yeast infection rates with the combination product 2, 3.
Risk Factors for Development
Patients at higher risk for developing yeast infections during Augmentin therapy include:
- Women (particularly those with history of recurrent vulvovaginal candidiasis)
- Longer duration of antibiotic therapy
- Recent or repeated antibiotic exposure
- Immunocompromised patients
Management Approach
When prescribing Augmentin, counsel patients about the risk of yeast infections and provide anticipatory guidance. For vulvovaginal candidiasis that develops during or after Augmentin therapy, the IDSA guidelines recommend topical antifungal agents or a single 150 mg oral dose of fluconazole for uncomplicated cases 6, 7, 6.
For patients with recurrent yeast infections, consider whether amoxicillin alone (without clavulanate) would be adequate for the indication, as the 2026 study demonstrated equivalent efficacy for acute sinusitis with lower adverse event rates 2. This aligns with antimicrobial stewardship principles of using the narrowest spectrum agent effective for the indication 8.
Common Pitfall
Do not dismiss patient concerns about yeast infections as unrelated to antibiotic therapy. The evidence clearly establishes this as a direct consequence of broad-spectrum antibiotic use, and the risk is quantifiable and clinically significant. Proactive counseling and early treatment of symptomatic candidiasis improves patient quality of life and medication adherence.